Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.80668 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.77858 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.80564 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.85164 | 40 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.7722 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.81236 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.78673 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77691 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.77099 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.77316 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.73487 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.77436 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.79282 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.7831 | 35 |